Sirolimus Solution
Product Images NDC 59762-1205

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Sirolimus (NDC 59762-1205). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sirolimus 01)

Chemical structure of sirolimus, the active ingredient in Sirolimus oral solution by Mylan Pharmaceuticals Inc., shown as a detailed molecular diagram with ring and chain structures indicating its complex composition.*

FDA Label Image

Figure 1 (Sirolimus 02)

A line graph depicting FEV1 (liters) over 24 months with two phases: Treatment Phase (0-12 months) and Observation Phase (12-24 months). Two groups are compared: Sirolimus (blue squares) and Placebo (open circles). Sirolimus group shows a higher and more stable FEV1 compared to the decreasing trend in the Placebo group. Number of subjects per group at various time points is listed below the graph.*

FDA Label Image

Logo (Sirolimus 03)

FDA Label Image

Logo (Sirolimus 03a)

FDA Label Image

Figure (Sirolimus 04)

An instructional diagram showing components for Sirolimus oral solution preparation, including a bottle labeled 'a,' an applicator or spoon labeled 'b,' two syringes labeled 'c,' a box or tray labeled 'd,' and two small round objects to the right of the syringes. The illustration aids in visualizing the dosing and administration tools for the medication.*

FDA Label Image

Figure (Sirolimus 05)

An instructional illustration showing a hand placing or removing a bottle cap that appears to have a tamper-evident safety ring. The image emphasizes the mechanism to break the ring when opening the bottle.*

FDA Label Image

Figure (Sirolimus 06)

An instructional illustration showing a hand holding an oral solution bottle labeled Sirolimus. The hand is shown removing the cap, indicated by a downward arrow, demonstrating how to open the bottle before use.*

FDA Label Image

Figure (Sirolimus 07)

An instructional illustration demonstrating the process of drawing oral solution with a syringe. The first panel shows a hand holding and pressing the syringe plunger. The second panel depicts the syringe inserted into a bottle, drawing the liquid upwards.*

FDA Label Image

Figure (Sirolimus 08)

An instructional black and white diagram depicting two hands preparing an oral solution of Sirolimus. One hand holds a vial while the other pulls up a syringe plunger to draw the solution from the vial, highlighted by a magnified inset showing the measurement markings on the syringe.*

FDA Label Image

Figure (Sirolimus 09)

An instructional illustration depicting a hand removing a protective cap from an oral syringe. The image shows the correct method to prepare the syringe for administering a solution dose, relevant to oral liquid medication like Sirolimus Oral Solution.*

FDA Label Image

Figure (Sirolimus 10)

An instructional illustration showing a hand holding a syringe above a plastic tray or packaging device, suggesting preparation for use or removal of a prefilled syringe. No drug labeling or text is visible in the image.*

FDA Label Image

Figure (Sirolimus 11)

An instructional illustration showing a liquid being dispensed from a syringe into a small cup, with an arrow indicating the direction of the liquid flow. This likely demonstrates the correct way to transfer the oral solution dose.*

FDA Label Image

Logo (Sirolimus 11a)

FDA Label Image

Principal Display Panel (60 mL Bottle Label)

Sirolimus 1 mg/mL oral solution label by Mylan Pharmaceuticals Inc., presented in a 60 mL bottle. The label identifies it as a Greenstone® brand product and includes usage instructions and ingredient details, specifying its content of 1 mg sirolimus per mL, ethanol, propylene glycol, and other components. It also notes the prescription-only status and storage guidance.*

FDA Label Image

Principal Display Panel (60 mL Bottle Carton)

Packaging label for Sirolimus oral solution 1 mg/mL by Greenstone brand, distributed by Greenstone LLC. The label is for a 60 mL bottle and includes usage instructions, storage conditions (refrigerate at 2° to 8°C), and ingredient information including sirolimus content and excipients such as ethanol, propylene glycol, phosphatidylcholine, soy lecithin, and polysorbate 80. The label features bar code and manufacturer details.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for Sirolimus oral solution 1 mg/mL by Greenstone brand, a 60 mL patient kit. The label includes product details such as concentration, ethanol content, and kit components including a 2 oz amber glass bottle, oral syringe adapter, syringes, caps, and carrying case. It also provides storage instructions to keep refrigerated and protect from light, plus directions and warnings about dosage and use. Labeler is Mylan Pharmaceuticals Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.